Cite

HARVARD Citation

    Gillmore, J. et al. (n.d.). Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. European heart journal. p. . [Online]. 
  
Back to record